Hite Christopher (CIK 1814238) reported 16 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-09-24). Recent activity: Sell RPRX (96,073 shares), Sell RPRX (3,927 shares), Sell RPRX (100,000 shares), Sell RPRX (16,800 shares), Buy RPRX (11,002 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-24 | Royalty Pharma plc (RPRX) | EVP & Chairman, Partnering | Sell | 96,073 | $5.6M |
| 2026-09-24 | Royalty Pharma plc (RPRX) | EVP & Chairman, Partnering | Sell | 3,927 | $231,403 |
| 2026-08-19 | Royalty Pharma plc (RPRX) | EVP & Chairman, Partnering | Sell | 100,000 | $6.0M |
| 2026-08-19 | Royalty Pharma plc (RPRX) | EVP & Chairman, Partnering | Sell | 16,800 | $0 |
| 2026-08-07 | Royalty Pharma plc (RPRX) | EVP & Chairman, Partnering | Buy | 11,002 | $0 |
| 2026-07-02 | Royalty Pharma plc (RPRX) | EVP & Chairman, Partnering | Sell | 97,446 | $5.5M |
| 2026-07-02 | Royalty Pharma plc (RPRX) | EVP & Chairman, Partnering | Sell | 2,554 | $145,841 |
| 2026-07-02 | Royalty Pharma plc (RPRX) | EVP & Chairman, Partnering | Sell | 29,400 | $1.7M |
| 2026-07-02 | Royalty Pharma plc (RPRX) | EVP & Chairman, Partnering | Sell | 600 | $34,254 |
| 2026-06-25 | Royalty Pharma plc (RPRX) | EVP & Chairman, Partnering | Sell | 32,408 | $1.8M |
| 2026-06-25 | Royalty Pharma plc (RPRX) | EVP & Chairman, Partnering | Sell | 117,592 | $6.4M |
| 2026-05-08 | Royalty Pharma plc (RPRX) | EVP & Vice Chairman | Buy | 24,263 | $0 |
| 2026-02-13 | Royalty Pharma plc (RPRX) | EVP & Vice Chairman | Buy | 26,626 | $0 |
| 2025-11-07 | Royalty Pharma plc (RPRX) | EVP & Vice Chairman | Buy | 6,168 | $0 |
| 2025-08-08 | Royalty Pharma plc (RPRX) | EVP & Vice Chairman | Buy | 3,696 | $0 |
| 2025-05-09 | Royalty Pharma plc (RPRX) | EVP & Vice Chairman | Buy | 48,646 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-09-24